Published in Cancer Weekly, May 1st, 2006
"Peptide-MHC tetramers have been engineered to allow accurate detection of antigen-specific cytotoxic T lymphocytes by flow cytometry. We propose a novel use for peptide-MHC tetramers in the specific and sensitive analysis of the cytotoxic function of antigen-specific CTL by blocking MHC-restricted antigen-specific cytotoxicity," scientists in Japan report.
"We found that pretreatment of ovalbumin (OVA)-specific CD8+ CTL (OT-1 CTL), derived from OT1 1T-cell receptor (TCR)-transgenic mice, with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.